Jifeng Hou Selected Research

Neutralizing Antibodies

1/2023	Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard.
1/2021	The first Chinese national standards for SARS-CoV-2 neutralizing antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jifeng Hou Research Topics

Disease

2	Severe Acute Respiratory Syndrome 01/2023 - 01/2021
2	COVID-19 01/2021 - 01/2020
1	Viremia 01/2020
1	Hemorrhage 03/2015
1	Virus Diseases (Viral Diseases) 03/2015

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 01/2023 - 01/2021
2	Neutralizing AntibodiesIBA 01/2023 - 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2020
1	PrionsIBA 03/2015
1	Fibrinogen (Factor I)FDA Link 03/2015
1	Hemostatics (Antihemorrhagics)IBA 03/2015

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020